Introduction
In the adult organism, hepatocyte nuclear factor 4a (HNF4a) is a cell-specific transcription factor and seems to play a crucial role in selective gene expression in liver, kidney, intestine, pancreas and stomach (Sladek and Seidel, 2001 ). In addition, HNF4a is necessary for normal embryonic development, since the inactivation of the gene in mice leads to early embryonic death due to dysfunction of the visceral endoderm (Chen et al., 1994) . Rescue of embryos lacking HNF4a showed that HNF4a is a key regulator essential for hepatocyte differentiation (Li et al., 2000) . This observation has been extended by liver-specific HNF4a deletion in the mouse embryo that revealed HNF4a as an essential hepatic factor to control lipid homeostasis (Hayhurst et al., 2001) as well as to form the hepatic epithelium and thus the normal liver architecture (Parviz et al., 2003) .
In DNA-binding studies and transactivation assays, several HNF4a target genes have been identified in hepatocytes, pancreatic b cells and embryonic stem cells. These studies have shown that HNF4a regulates specific genes and these are partially dependent on the cell type. As chromatin immunoprecipitations in hepatocytes and pancreatic islands have shown that HNF4a is bound to a 5-10-fold higher number of promoters than the transcription factors HNF1a and HNF6 (Odom et al., 2004) , it has been proposed that HNF4a regulates an unusually large set of genes. The function of HNF4a has been best characterized in the liver where it is essential for the regulation of the genes involved in metabolism of glucose, amino acid, lipid and xenobiotic as well as genes encoding secreted proteins involved in lipid transport, blood coagulation and hematopoiesis (Sladek and Seidel, 2001 ). In humans, heterozygous mutation in the HNF4a gene causes MODY1 (maturity onset diabetes of the young), a rare form of diabetes mellitus characterized by an early onset and a primary defect in glucose-stimulated insulin secretion of the pancreatic b cells (Hattersley, 1998; Ryffel, 2001 ). This documents the important role of HNF4a in b cells of the pancreas where it regulates expression of genes involved in glucose metabolism and insulin secretion (Wang et al., 2000) . Recently, we have shown by gene expression profiling that HNF4a is able to affect the activity of 338 probe sets in the rat insulinoma cell line INS-1 (Thomas et al., 2004) .
In the kidney only little is known about the physiological role of HNF4a, although it is highly expressed in some sections of this organ. Based on gene expression profiling in dissected kidneys, abundant expression in the proximal convoluted and straight tubules has been reported, whereas the other sections lack significant expression (Chabardes-Garonne et al.
(2003); NCBI, GEO Profiles, GDS503 HNF4A). This finding has been confirmed on the protein level where HNF4a has been detected in proximal tubular epithelial cells, but is absent in the glomerulus as well as in distal and collecting tubular epithelial cells (Jiang et al., 2003) . So far in kidney cells only the a-1-microglobulin/bikunin precursor gene (AMBP) has been identified as gene regulated by HNF4a (Grewal et al., 2004) .
Several years ago we analysed the possibility that defective HNF4a function may play a role in tumor formation. Whereas no consistent changes in HNF4a were seen in chemically induced rat hepatomas (Stumpf et al., 1995) , the analysis of human renal cell carcinoma (RCC) revealed that the abundance and the DNAbinding activity of HNF4a protein is frequently reduced in the carcinoma compared to the normal tissue (Sel et al., 1996) . This finding was confirmed by comparing gene expression profiles of RCC with normal tissue showing 4.7-fold downregulation of HNF4a mRNA (Lenburg et al., 2003) . So far, only a limited number of genes including VHL (von Hippel-Lindau) and MET (cmet protooncogene, hepatocyte growth factor receptor) has been identified, which play a key role in the initiation and progression of RCC (Linehan and Zbar, 2004) . Other genes are most likely involved in renal carcinogenesis and clearly a transcription factor such as HNF4a that is downregulated is a candidate. Based on the lack of information on the significance of HNF4a in kidney cells, we explored in the present report whether HNF4a has some properties indicating its role in renal cell carcinogenesis. As a model for kidney cells, we used the human embryonic kidney cell line HEK293 that represents a cell type along the differentiation from the condensed mesenchyme to the S-shaped body in early nephrogenesis (Torban and Goodyer, 1998) . By conditional expression of HNF4a in these kidney cells, we investigated whether HNF4a influences proliferation. Using oligonucleotide microarrays, we analysed what genes are regulated by HNF4a in HEK293 cells and whether these genes are related to genes that are deregulated in RCC.
Results

Generation and characterization of the HEK293 cells with inducible HNF4a
To test whether the tissue-specific transcription factor HNF4a has the potential to influence proliferation of kidney cells, we used the Flp-In T-REx system (Invitrogen) to generate cell lines that express HNF4a in a tetracycline inducible fashion. We used the well-characterized human embryonic kidney cell line HEK293 as a model for kidney cells, as this cell line lacks HNF4a expression. To introduce HNF4a, we used the myctagged splice variant HNF4a2 we have previously cloned from human kidney that is characterized by a 10 amino-acid insert in the carboxy-terminal F domain (Sladek and Seidel, 2001) . To monitor whether the HNF4a-mediated effects are specific, we also generated cells expressing the HNF4a mutants C106R and R154X (Figure 1a ). The construct C106R is an artificial mutant with a point mutation in the second zinc-finger of the DNA-binding domain and has been reported to act as a loss-of-function mutation with a weak dominant negative effect (Taylor et al., 1996) . In contrast, the nonsense mutant R154X is a MODY1-associated mutant that encodes a truncated protein that has lost most of its transcriptional activity (Laine et al., 2000; Lausen et al., 2000) . In the following, we report the properties of two independent HNF4a wild-type cell lines (wt#1 and wt#4) and as controls one cell line for each HNF4a mutant (C106R#1 and R154X#6) as well as a cell line containing GFP (GFP#7).
The established cell lines were evaluated for tetracycline induction of the appropriate HNF4a constructs by Western blotting and immunofluorescence using a myc tag-specific antibody. In the absence of tetracycline, the HNF4a derivatives were not detected in the cell lines demonstrating that the genes are effectively repressed by the Tet-repressor (Figure 1b-d) . The addition of tetracycline to the culture medium caused rapid transcriptional activation of all HNF4a genes. High protein levels were detected as early as 3 h after induction and HNF4a levels continued to rise reaching maximum levels at 24 h following activation as shown for HNF4a wt#1 in Figure 1b . In all the independent cell lines, the kinetics and extent of HNF4a induction was similar. Only the extent of induction of the truncated mutant R154X was consistently lower compared to the induction of full-length proteins (Figure 1c) , suggesting a lower stability of the truncated protein. By immunofluorescence, we observed in all cell lines the nuclear localization of the induced protein and more than 95% of the cells contained HNF4a 24 h after induction with tetracycline. Figure 1d shows HNF4a wt#1 as an example. Taken together, these data establish a most reproducible induction of the HNF4a derivatives in the various cell lines.
HNF4a reduces proliferation in HEK293 cells
To evaluate whether HNF4a affects cell proliferation, we compared the proliferation rate of the uninduced and induced cells that express the different HNF4a constructs. First, we counted the number of cells after different days of tetracycline induction. The cell lines wt#1 and wt#4 revealed a significantly reduced cell growth upon HNF4a induction compared to the uninduced cells. This effect was clearly evident from 3 days onwards (Figure 2a , upper panels). In contrast, no difference in the increase in cell number was detected upon tetracycline treatment of the cells lines C106R#1 and R154X#6 expressing the HNF4a mutants ( Figure 2a , lower panels). The reduction in cell growth rate upon HNF4a expression was confirmed by the MTS assay that measures the number of cells based on their metabolic activity (Figure 2b ). This inhibition was specific, as the expression of the HNF4a mutants or GFP did not interfere with cell growth. This inhibitory HNF4a reduces proliferation of kidney cells B Lucas et al effect induced by HNF4a induction was also seen on gelatin-coated plates ( þ g in Figure 2b ). This excludes the possibility that the change in cell morphology mediated by HNF4a (see below) triggers suboptimal growth, because an attachment surface is lacking. To further explore the effect, we analysed whether the overexpression of HNF4a leads to a reduction in the number of cells in the S phase. The measurement of BrdU incorporation using BrdU ELISA (Figure 2c) shows that the induction of HNF4a but not the induction of the mutants led to a decrease in the number of S-phase cells. However, this reduction correlates with a corresponding decrease in the cell number and thus no significant change in the percentage of S-phase cells was seen. The lack of a decrease in the Sphase cell population was also confirmed by displaying BrdU-positive cells using FACS analysis and immunohistochemistry (data not shown).
Furthermore, we examined whether the decrease in the cell growth is due to an induction of apoptosis. Measuring apoptosis by three independent methods, that is, propidium iodine staining in FACS, annexin staining and measuring caspase 3/7 activity, no evidence for an increase in apoptotic cells upon HNF4a expression was observed. As a representative result, we include the caspase-3/7 assay in Figure 2d . Based on these data, we conclude that HNF4a interferes with the multiplication of kidney cells but this interference is not due to an activation of apoptosis.
HNF4a induces morphological changes in HEK293 cells
After induction of HNF4a, we observed a marked change of morphology in HEK293 cells with time. We assessed the morphological change by phase-contrast microscopy ( Figure 3a and b) , by staining of the nuclei with Hoechst 33342 and by displaying the actin filaments by actin-phalloidin staining (Figure 3c ). The control cells that exhibited a small, polygonal-shaped, epithelial-like morphology formed a closely packed monolayer at confluence. In contrast, cells expressing HNF4a failed to grow in an epithelium-like monolayer. Starting at day 2 after HNF4a induction, the cells changed to a rounded phenotype, the elongated dendritic projections from the cytoplasm disappeared and the cells clumped together building aggregates (Figure 3 ). This change in cell morphology was also seen on gelatin-coated plates (data not shown). However, no detachment of cells was observed that could explain a loss of cells with time. All these morphological changes were specific for HNF4a expression, as the expression of the mutants R154X and C106R did not alter the morphology of HEK293 cells (data not shown). (Sladek and Seidel, 2001 ) and the numbers refer to the amino acid in wild-type human HNF4a2. All the constructs contain a myc-tag at the N-terminus. (b) Time course analysis for HNF4a wt#1. Tetracycline (Tet) was added for the time indicated and Western blot analysis was performed using the monoclonal antibody 9E10 that recognizes the myc-tag (10 mg protein lysate per lane). (c) The cell lines HNF4a wt#1 and wt#4, C106R#1 and R154X#6 were left uninduced (48 h) or induced for 24 and 48 h with 1 mg/ml tetracycline. Protein extracts (2 mg) were probed by Western blotting using the myc-specific antibody 9E10. The mutation R154X leads to a truncated protein that migrates faster than the full-length protein. To analyse whether the changes induced by HNF4a were reversible, we treated the cells with tetracycline for 2 days and then replaced the medium without adding tetracycline. Using this protocol, we observed that the cells whose morphology had changed initially reversed to the normal shape ( Figure 4a ) and regained their normal growth properties ( Figure 4b ). We conclude from these results that the effect of HNF4a on growth and morphology of the HEK293 cells is reversible.
In the experiments shown so far, we induced the expression of HNF4a by treating the cells with 1000 ng/ ml tetracycline and thus achieved the highest possible expression level (data not shown). To evaluate the induced HNF4a level in our HEK293 cell lines, we compared by Western blots the abundance of HNF4a between HEK293 cells and the hepatoma cell line HepG2. Although this widely used human hepatoma cell line contains a missense mutation in one HNF4a allele, it is a valid differentiated cell type for standardization, as we have shown that both alleles are expressed at similar levels and the corresponding proteins have comparable stabilities (Lausen et al., 2000) . Comparing the induced HNF4a protein level in HEK293 cells with the level in the human hepatoma cell line HepG2, we estimate in the induced HEK293 cells a HNF4a protein level approximately five times higher than in HepG2 cells (compare lane 4 and 5 in Figure 5a ). By inducing with 10 ng/ml tetracycline, we achieved a level that is slightly lower than in HepG2 cells (lane 3 and 5), and by inducing with 5 ng/ml tetracycline we obtained approximately one-fourth of the level in HepG2 cells (lane 2 and 7). Using these limiting conditions to induce HNF4a, we still observed a significant interference with cell growth, but to a lower extent (Figure 5b ). The effect on cell morphology was seen at 10 ng/ml tetracycline but was absent using 5 ng/ml tetracycline. This indicates that s AQueous One Solution Cell Proliferation Assay (MTS, Promega). Cell viability is given in percent of the appropriate uninduced controls. The results are means7s.d. of three independent experiments, each run in triplicate. Assays given with broken line were carried out in plates coated with 0.1% gelatine ( þ g). (c) BrdU ELISA cell proliferation assay. Cells were synchronized for 48 h in medium containing 0.2% FCS and then kept uninduced or induced in medium containing 10% fetal calf serum (FCS) for the indicated time. Cells were pulsed for BrdU incorporation for 1 h and ELISA was performed according to the manufacturer's instructions (Cell Proliferation ELISA BrdU Assay, Roche Molecular Biochemicals). To determine the number of cells, the MTS assay was performed in the same wells. (d) Apoptosis assay. Cells containing the different HNF4a constructs were seeded into 96-well culture plates. After 3 days of tetracycline induction, caspase activity was measured using the Caspase-Glot 3/7 Assay (Promega). The cell number was determined in parallel plates using the MTS assay. Data are the mean7s.d. from a representative experiment that was repeated twice with similar results. As a control, the cell line HNF4a wt#1 was cultured in addition without FCS (ÀFCS) resulting in caspase activation 
Identification of genes regulated by HNF4a in HEK293 cells
Since HNF4a is a transcription factor regulating the expression of target genes, its growth inhibitory effect in HEK293 cells is most likely a consequence of affecting the expression of specific HNF4a target genes. To identify the genes regulated by HNF4a in HEK293 cells, we used the Affymetrix GeneChip DNA oligonucleotide microarray HG_U133A that contains 22 283 probe sets detecting the expression of approximately 18 400 human transcripts. The RNA from the two independent HNF4a cells lines wt#1 and wt#4 as well as the mutant cell lines R154X#6 and C106R#1 was isolated after 24 h tetracycline treatment or after 24 h ethanol treatment as a control and was analysed on microarrays. Using this comparative analysis, we identified 65 genes that were differentially expressed in both cell lines with 57 genes upregulated and eight genes downregulated. As none of these genes was regulated in the mutant cell lines R154X#6 and C106R#1, we deduce that they are specifically regulated by HNF4a. To qualify the genes upregulated by HNF4a in HEK293 cells, we applied a tissue-specific gene expression ranking as reported recently (Lim et al., 2005) . Using the gene expression profiles from 33 human tissues that were assayed on the same GeneChip (Affymetrix HG_U133A), we generated an index of relative gene expression for these 33 tissues by first ranking the expression levels of each gene over all tissues, whereupon the gene ranks for each tissue were plotted. Figure 6a shows a histogram of the expression of all genes in the kidney where the left-most column (rank 1) represents the number of genes that are expressed more highly in the kidney than in any of the other tissue and the right most column (rank 33) represents the genes expressed less in kidney than in any other tissue. The distribution of the kidney ranking for the genes upregulated by HNF4a (Figure 6b ) differs from the distribution of the entire set of genes by a preferential enrichment of genes that are expressed at high level in the kidney. Applying this analysis to all 33 tissues, we observed additional significantly increased ranks in the liver, lung, pancreas and fetal liver ( Figure 6c) . Thus, the genes upregulated by HNF4a in HEK293 cells encode predominantly transcripts that are abundant in tissues expressing the tissue-specific transcription factor HNF4a (kidney, adult and fetal liver as well as pancreas), and also in the lung where HNF4a is absent . Two tissues with high HNF4a level (stomach and small intestine) were not included in the 33 tissue samples available.
To confirm the results observed by the microarray analysis, real-time quantitative RT-PCR was used to validate the expression of 48 genes. Gene expression was analysed in the cell lines wt#1 and wt#4 as well as the mutant C106R#1 24 h after tetracycline induction and in the corresponding untreated cells. In Table 1 , the mean of the results for two independent RNA preparations is shown. For 46 genes we were able to confirm the results of the gene arrays. Only two genes, that is, peripherin and CIDEB could not be verified (bottom of Table 1 ).
The genes identified by microarray and RT-PCR are involved in many different processes as based on Gene Ontology and they are listed accordingly in Table 1 . A great number of regulated genes are involved in metabolism, transport and signal transduction. Interestingly, several genes encode cell adhesion proteins (collagen type XXI alpha 1, plakophilin 2, desmocollin 2, chondroitin sulfate proteoglycan 2) or components of the cytoskeleton (villin 1, syndecan 4, LIM and SH3 protein 1, neurofilament light polypeptide). The activity of these genes may contribute to the observed changes in morphology of HNF4a-expressing cells. Based on Gene Ontology, about a quarter of the HNF4a-regulated genes lack a functional assignment.
HNF4a increases the level of WT1 and villin 1 protein
As Wilms tumor 1 (WT1) and villin 1 are two interesting HNF4a-regulated genes that could be responsible for the changes in proliferation and morphology, respectively, we determined the level of these two proteins using specific antibodies. In a Western blot, we observed in both cell lines expressing HNF4a a significant increase in WT1 and villin 1 protein compared to Figure 4 The effect of HNF4a on proliferation and morphology is reversible. At 2 days after induction in an induced set of wells, the medium was replaced with tetracycline-free medium (7Tet). (a) Cell morphology is shown after 2 days of induction and 2 or 4 days later after removing of tetracycline. (b) Cell number was assessed daily using the MTS assay HNF4a reduces proliferation of kidney cells B Lucas et al control cells (Figure 7) . Therefore, the increase found on the RNA level is reflected on the protein level for both these probes.
Several genes regulated by HNF4a in HEK293 cells are deregulated in RCC
To determine whether HNF4a-regulated genes in HEK293 cells are also changed in RCC, we compared the 1234 genes that are more than threefold changed in RCC (Lenburg et al., 2003) with the genes we have identified. In this comparison, we find that 15 of the 65 HNF4a-regulated genes in HEK293 cells are also differentially expressed in RCC (Table 2 ). Of these 15 common genes, 13 are regulated in opposite direction in the induced HEK293 cells compared to RCC as expected for genes altered in their activity in RCC due to HNF4a downregulation. Therefore, we propose that the downregulation of 10 genes, that is, ACY1, WT1, SELENBP1, COBL, EFHD1, AGXT2L1, ALDH5A1, THEM2, ABCB1 and FLJ14146, in RCC may be a consequence of the decreased HNF4a level. We also speculate that CSPG2, TRIM9 and HEY1 are upregulated in RCC, because these genes are HNF4a target genes that according to our results in HEK293 cells are downregulated by HNF4a. In conclusion, a subset of the HNF4a-regulated genes of HEK293 cells is changed in activity in RCC, indicating a potential involvement of HNF4a in these transcriptional changes in RCC.
Analysis of candidate target genes for mediating the effects of HNF4a
We choose the four HNF4a-regulated genes WT1, MTM1, SEPP1 and DSC2 as candidate target genes for mediating the effect of HNF4a on proliferation and morphology. To explore whether the activation of these genes could mediate the HNF4a effects, we created two independent cell lines conditionally expressing each of these proteins. Thus, the corresponding cDNAs were inserted into the pcDNA5/FRT/TO vector and integrated into the HEK293 cell lines by Flp-In recombination in the same way as done for HNF4a. For the WT1 gene, we established cells expressing the splice forms c or d. These two splice variants were most likely upregulated, as the regulated probe set of the microarray detects all four splice variant, whereas a probe set detecting splice variant a and b was not regulated. In all the cell lines created, the transcripts were effectively induced upon tetracycline treatment (data not shown). However, in none of these cell lines, a change in morphology was observed upon tetracycline induction (data not shown). Furthermore, based on MTS assay, we deduce that the expression of WT1, MTM1, SEPP1 or DSC2 is not sufficient to inhibit cell proliferation (Supplementary Figure S1 ).
Discussion
We demonstrate that HNF4a inhibits proliferation of kidney cells by conditionally expressing HNF4a in the human embryonic kidney cell line HEK293. Our finding confirms recent data in murine hepatoma (Lazarevich et al., 2004) as well as endothelial and embryonal carcinoma cells (Chiba et al., 2005) and indicates that the regulation of proliferation by HNF4a is a phenomenon common to different cell types. Significantly, our data establish that physiological levels of HNF4a are sufficient to elicit this antiproliferative effect.
The reduction of proliferation was accompanied by a failure to grow in an epithelium-like monolayer. This morphological change is opposite to other studies showing the formation of a epithelial phenotype in murine hepatoma cells (Lazarevich et al., 2004) and in NIH3T3 mouse fibroblasts (Parviz et al., 2003) .
As HNF4a is a transcription factor, it is likely that the effect is mediated by transcriptional gene activation. However, the liver-enriched transcription factor C/EBPa mediates inhibition of proliferation by proteinprotein interaction with cyclin-dependent kinases . Our finding that the full-length zinc-finger mutant C106R has no effect on cell multiplication strongly argues for some HNF4a target genes involved in proliferation control. Therefore, we performed oligonucleotide microarrays and identified 65 genes that are regulated by HNF4a expression. We report the analysis at 24 h after tetracycline induction to measure transcriptional effects preceding the phenotypic effects starting at 2 days of induction. Microarrays made after 12 h of induction (data not shown) gave lower effects, whereas real-time RT-PCR revealed a gradual increase Figure 6 Tissue-specific gene expression rankings for HNF4a-upregulated genes. (a) Background kidney ranking of 21 879 probe sets. The expression levels of each probe set of the GeneChip HG_U133A were sorted according to their rank in a collection of 33 human tissues selected from GDS596 in the NCBIs Gene Expression Omnibus database. Except for two tissues (salivary gland and testis), where replicates exhibiting very poor RNA quality were excluded, the mean signals were used. Probe sets that showed mean signals below 100 in all tissues were excluded from the analysis and the remaining signal values below 100 were adjusted to 100 prior to rank assignment. (b) Kidney ranking for 66 probe sets corresponding to the 57 genes upregulated by HNF4a in HEK293 cells. Ranks were determined as in (a). (c) The ranking of the HNF4a target genes in each tissue was compared to the corresponding background ranking using a one-sided Mann-Whitney test. Log (base10) P-values are plotted for each of the 33 tissues. *** and * refer to P-values o0.0001 and o0.05, respectively. Colon cancer refers to colorectal adenocarcinoma and all the other tissues were normal for many transcripts up to 4 days of induction (data not shown), but no evidence for early and late responding genes could be established. The majority of the genes is upregulated showing that HNF4a is mainly a positive regulator of transcription. This result was also obtained in a previous microarray study in hepatoma cells (Naiki et al., 2002) and to a lower extent in pancreatic b cells (Thomas et al., 2004) . Our gene expression profiling is the first systematic analysis to identify genes regulated by HNF4a in a kidney cell line and this possibly explains why most of the genes identified in our experiments represent new HNF4a-regulated genes. Comparing the genes obtained in our study with the 62 HNF4a-regulated gene in the human hepatoma cell line HuH-7, only aminoacylase 1 (ACY1) was common (Naiki et al., 2002) . With the 338 probe sets found to be regulated in pancreatic b cells (Thomas et al., 2004) , a limited overlap was seen as well with four genes (ACY1, ERBB3, ETFDH and SLC25A20) in common. This gives further evidence that tissue-restricted transcription factors affect gene activities in a cell type-specific manner.
HNF4a reduces proliferation of kidney cells B Lucas et al
Considering the function of the HNF4a-regulated genes in HEK293 cells, we find only one gene potentially involved in cell proliferation (Table 1) . However, the expression of this gene (GAS1, growth arrest specific 1) known to block cell proliferation (Del Sal et al., 1994 ) is downregulated and thus was not analysed further. Another candidate involved in proliferation control is the Wilms tumor 1 (WT1) gene whose upregulation was also seen on the protein level (Figure 7) . The effect of WT1 on growth is well documented but seems to be complex, as both positive and negative effects on proliferation have been reported (Wagner et al., 2003) . However, based on our conditional overexpression of WT1 that lacked any effect on cell proliferation, we exclude WT1 as a key player. However, we cannot exclude that WT1 is essential in concert with other gene activities altered by HNF4a expression. In this context it is interesting that WT1 has been reported to downregulate HNF4a in hepatocytes (Berasain et al., 2003) , suggesting a negative feed back between these two transcription factors. Based on the Affymetrix U133A microarray analysis, genes upregulated (X2.0-fold, Po0.001) or downregulated (p0.5-fold, P>0.999) in the two HNF4a cells lines wt#1 and wt#4 after 24 h of induction are listed. For the genes HNF4A, MAN1A1, ABCB1, CFLAR, ATXN7L1///4 and CALML4, two probe sets and for the genes DDAH2 and AKAP1 three probesets were scored and therefore the mean of the signals of the different probe sets is given. All the microarray data have been deposited in GEO (http://www.ncbi.nlm.nih.gov/geo). Quantitative real-time RT-PCR was performed on 48 genes using TaqMan s Low Density Array (Applied Biosystems). The same RNA used for the microarray and an RNA from an independent experiment were used. The mean of the results for the two independent RNA preparations is shown. ND: genes not determined in the real-time RT-PCR analysis Figure 7 Validation of the microarray candidate target genes WT1 and villin 1 by Western blot. Proteins (20 mg) derived from untreated cells or cells treated for 24 h with tetracycline of both cell lines containing HNF4a were loaded onto a 10% SDS gel and immunoblotted with antibodies specific for WT1, villin 1 and actin. For WT1, four isoforms marked by dashes were detected. The actin used as a control was slightly downregulated in both cell lines
The genes induced by HNF4a (Table 1) include three genes (TRAF4, CFLAR and BIRC2) that are associated with apoptosis. However, as we did not get any evidence of apoptosis (Figure 2d ), we assume that these changes are either not sufficient to get an apoptotic effect or are not reflected on the protein level.
The changes in the expression observed in genes encoding components of the cytoskeleton and involved in cell adhesion (Table 1 ) may contribute to the morphological changes observed in the cells, but could possibly act in a more indirect way on cell proliferation as well. Based on conditional expression of the genes DSC2, MTM1 and SEPP1, we exclude that they mediate the morphogenic effect and proliferation control induced by HNF4a. Our data establish that villin1 is upregulated on the RNA level (Table 1) as well as on the protein level ( Figure 7) . As villin 1 is a member of the gelsolin superfamily that are known to remodel the actin filaments by severing these filaments (Silacci et al., 2004) , we speculate that this process participates in the HNF4a-mediated shift from the epithelial-like morphology to the rounded phenotype.
Several reports have linked HNF4a to the formation of hepatocellular carcinoma (HCC). Whereas chemically induced HCC in rat failed to show a decrease in HNF4a (Stumpf et al., 1995) , HNF4a expression showed a close correlation with HCC differentiation and was proposed to be a useful marker to assess the degree of HCC differentiation in humans (Ishiyama et al., 2003) . A systematic investigation of human HCCs including microarray analysis has shown in some (Choi et al., 2004) but not all HCCs (Xu et al., 2001 ) a decrease in HNF4a. Using a mouse model for the progression of HCC from a slow-growing to a fast-growing form it has been demonstrated that HNF4a has a critical role in the progression of HCC, since forced re-expression of HNF4a reversed the progressive phenotype (Lazarevich et al., 2004) .
In the case of RCC, we had observed a consistent down-regulation of HNF4a protein in the tumors compared to the normal tissue (Sel et al., 1996) . With the availability of DNA microarrays, systematic gene expression profiling has been performed in RCC (Boer et al., 2001; Young et al., 2001; Gieseg et al., 2002; Higgins et al., 2003; Takahashi et al., 2003) . However, in most studies, the activity of HNF4a was not assessed possibly due to the fact that the methods used were not sufficiently sensitive for rare transcripts. A notable exception has been published showing 1234 genes that are differentially expressed in RCC by threefold or more compared to the normal tissue (Lenburg et al., 2003) . These transcripts include HNF4a that is downregulated by a factor of 4.7. We assume that the 13 genes regulated in RCC in the way expected for HNF4a target genes (Table 2) are good candidates for genes whose activity is changed upon the decrease of HNF4a.
Searching for mutations in the human HNF4a gene in tumor material, we could only find a missense mutation in the hepatoma cell line HepG2 (Lausen et al., 2000) . However, it is not clear whether this mutation was a causative event in the hepatoma formation. To further explore the significance of HNF4a for carcinogenesis in humans, it might be instructive to analyse whether specific variants of the HNF4a protein, which are known to cause MODY or are believed to be associated The values for RCC are derived from published microarray data (Lenburg et al., 2003) . The value given for the fold change in the microarray and real-time RT-PCR is the average of the two cell lines HNF4a wt#1 and wt#4. ND: genes not determined in the real-time RT-PCR analysis
with the more common type II diabetes (Ryffel, 2001; Gupta and Kaestner, 2004) , predispose also to RCC. The downregulation of HNF4a in RCC could be interpreted as an indication that HNF4a plays a role as a tumor suppressor. However, the argument that RCC is initiated of a cell type lacking HNF4a expression cannot be rigorously excluded. The evidence provided by our work and the recent data by others (Lazarevich et al., 2004; Chiba et al., 2005) strengthen the hypothesis that HNF4a has a tumor suppressing activity, since it inhibits cell proliferation. In future, it will be a major challenge to dissect which target genes of HNF4a are mediating the reduction of proliferation and the change in cell morphology.
Materials and methods
Plasmid constructs
Human mycHNF4a2 and mycHNF4a2 R154X sequences were cloned as NotI fragment from the expression vector pOPI3 (Lausen et al., 2000) into the plasmid pcDNA5/FRT/TO (Invitrogen). The C106R mutation was made by site-directed mutagenesis (Quick Change site-directed mutagenesis kit; Stratagene) on the pcDNA5/FRT/TO HNF4a2 using the primers 5 0 -CCAGTGCCGCTACCGCAGGCTCAAG-3 0 and 5 0 -CTTGAGCCTGCGGTAGCGGCACTGG-3 0 and verified by sequencing. GFP was derived as HindIII-XhoI fragment from pCSGFP2 and cloned into HindIII-XhoI-digested pcDNA5/FRT/TO. Human WT1 c and d sequences were excised as XbaI fragment from CMV WT1 (À/ þ ) and CMV WT1 ( þ / þ ), respectively (a kind gift of V Schumacher), cloned into pBluescript II SK þ (Stratagene) and the KpnI/NotI fragment inserted into the pcDNA5/FRT/ TO vector. Human DSC2 was derived as KpnI/BamHI fragment from pKS-DSC2myc (a kind gift from KJ Green, Kowalczyk et al., 1994) and cloned into the KpnI/BamHIdigested pcDNA5/FRT/TO. Human MTM1 was excised with BamHI from the pCS2-hMTM1 vector (a kind gift of J Laporte, Blondeau et al., 2000) and cloned into the BamHI site of pcDNA5/FRT/TO. Human SEPP1 was derived as BamHI/ XhoI fragment from pBluescriptSK-hSEPP1 (a kind gift of KE Hill, Hill et al., 1993) and cloned into the BamHI/XhoIrestricted pcDNA5/FRT/TO.
Generation and induction of stable cell lines
As a recipient cell line, we used the Flp-Int T-RExt 293 cells (Invitrogen) that contain the tetracycline repressor as well as the FRT site and have been derived from the human embryonic cell line HEK293. Stable cell lines were established by cotransfecting the pcDNA5/FRT/TO constructs together with the Flp recombinase expression plasmid pCSFLPe (Werdien et al., 2001) using LipofectAMINEt (Invitrogen). Cells that had inserted the plasmid into the single FRT site of the Flp-Int T-RExt 293 cells were selected in medium containing 50 mg/ml hygromycin B (Invitrogen). As the transgenes are integrated at the same chromosomal site, cell lines were prepared by pooling the colonies. The success of site-directed integration was verified by staining the cells for bgalactosidase activity. Cell lines with less that 5% blue cells were used for further experiments. After selection, cell lines were maintained in DMEM containing penicillin (100 U/ml), streptomycin (100 U/ml), 2 mM L-glutamine, 10% heat-inactivated FCS, 15 mg/ml blasticidin and 50 mg/ml hygromycin B.
For activation of the transgene, cells were cultured in medium containing 1 mg/ml tetracycline unless described otherwise. Since tetracycline is dissolved in ethanol, ethanol was added to the culture media of control cells. In all the experiments, cells were seeded 24 h before tetracycline induction. As tetracycline has a half-life of 24 h, it was added to the culture media every other day. The cells were routinely checked for mycoplasm contamination and were negative on all occasions.
Western blot analyses and immunofluorescence
Cell pellets were lysed in RIPA buffer (50 mM Tris-HCl pH 7.2, 150 mM NaCl, 0.1% sodium dodecylsulfate, 1% sodium deoxycholate, 1% Triton X-100) supplemented with protease inhibitor cocktail (Sigma P-8340). Insoluble debris were removed by centrifugation at 14 000 g for 10 min at 41C. The protein concentration of the supernatant was determined using a Bradford assay (Bio-Rad). Equal amounts of proteins were separated on SDS-polyacrylamide gels and transferred to nitrocellulose. Membranes were blocked with blocking reagent (RPN 3601, Amersham). For antigen detection, monoclonal anti-myc tag antibody 9E10, anti-HNF4a (Santa Cruz, C-19, 1 : 1000), anti-WT1 (Santa Cruz, C-19, 1 : 1000), anti-villin (Transduction Laboratories, 1 : 1000) and anti-actin (Santa Cruz, I-19. 1 : 5000) were employed. Peroxidase-conjugated anti-mouse IgG (Amersham), anti-rabbit IgG (Jackson ImmunoResearch) and anti-goat IgG (Sigma) were used as secondary antibodies. Immunoreactivity was detected by ECL (Amersham Biosciences). Myc immunofluorescence was performed with cells fixed in methanol as described (Lausen et al., 2000) . For phalloidin staining, cells were fixed in 4% paraformaldehyde in PBS and permeabilized with 0.1% Triton X-100 in PHEM buffer containing a 1/100 dilution of FITCcoupled phalloidin (Sigma). Hoechst 33342 dye (1 mg/ml) was used to label the nuclei.
Measurement of cell growth rate, BrdU incorporation and caspase activity
For cell counting, cells were seeded at a density of 2 Â 10 4 cells/ well into 12-well plates (in duplicate) 24 h before addition of tetracycline. Cells were treated with 1 mg/ml tetracycline or 1 ml/ml ethanol as control. For each time point, cells were trypsinized and the cell number assessed using a hematocytometer. MTS assays were performed according to the manufacturer's instructions (CellTiter 96 s AQueous One Solution Cell Proliferation Assay, Promega) in a 96-well plate. After 24 h, cells were kept uninduced or treated with tetracycline for the desired time period. Each experiment was performed in triplicate and repeated at least three times. Cell viability in percent refers to the MTS value of the induced cells compared to the value of the ethanol-treated control cells. To determine DNA synthesis, we used the Cell Proliferation ELISA BrdU Assay (Roche Molecular Biochemicals) according to the manufacturer's protocol. Cells cultured in 96-well plates were pulse labeled for 1 h with 10 mM BrdU and the measurements were performed on an ELISA reader at 450 nm. Experiments were repeated three times per triplicate. Caspase 3/7 activity was measured in white-walled 96-well plates using the Caspase-Glot 3/7 Assay (Promega).
Oligonucleotide microarray analysis
Total RNA was isolated using peqGOLD RNA-Pure s (peqlab) as described by the manufacturer. The RNA was further purified using the RNeasy kit (Qiagen) according to the standard protocol including on-column digestion of DNA with RNase-free DNaseI. cDNA synthesis, synthesis of biotinylated HNF4a reduces proliferation of kidney cells B Lucas et al cRNA and hybridization to HG_U133A microarrays (Affymetrix) were performed as described (Thomas et al., 2004) . Data were analysed using Microarray Suite 5.0 software (Affymetrix). In the comparison analysis ( þ Tet versus ÀTet) probe sets exhibiting a fold change value X2.00 and a change P-value o0.001 or a fold change value p0.50 and a change Pvalue >0.999 were identified using the Affymetrix Data Mining Tool 3.0 and only those passing these cutoffs in both independent cell lines and not in the mutant cell line were considered as targets. In addition, candidates had to score at least one present call in the uninduced versus induced sample pair. The microarray data have been deposited in NCBIs Gene Expression Omnibus (GEO, http:// www.ncbi.nlm.nih.gov/geo/) and are accessible through GEO Series accession number GSE2700.
Quantitative real-time PCR
In total, 5 mg of total RNA isolated with the RNeasy kit (Qiagen) were reverse transcribed in a final volume of 50 ml using the High Capacity cDNA Archive Kit with random primers (Applied Biosystems). Quantitative real-time PCR was performed on an ABI PRISM s 7900HT Sequence Detection System using TaqMan s Low Density Array (Applied Biosystems). In the chosen configuration, the FAM-labeled TaqMan s probes (Assays-on-Demand, Applied Biosystems) were lyophilized in duplicate on the microfluidic card. 1 Â TaqMan s Universal PCR Mix (Applied Biosystems) and cDNA probes corresponding to 400 ng RNA were added to each port of the array and the reaction was performed according to the manufacturer's instructions. Each cDNA probe was analysed in duplicate for a specific transcript. GAPDH was used to normalize for RNA loading. Gene expression was quantified using the 2
ÀDDCt method comparing the C T value of induced and uninduced cells.
